Contest Trader

Don't miss the chance to cash-in prizes totaling

$10.000
Register here for the Ultimate demo trading competition

A potential vaccine made the markets go round - Tuesday Review, August 25

A potential vaccine made the markets go round - Tuesday Review, August 25

The global markets were high on hope

The US

The benchmarks have been pushed higher by a possible COVID-19 #vaccine and Jerome Powell's speech due on Thursday. USA30 fell 0.21%, while USA500 rose 0.36%. TECH100 closed at an all-time high after it gained 0.76%.

#Oil prices reached their highest level in almost six months as Hurricane Laura nearly hit a couple of refineries in the US. Crude Oil added 1.9% to $43.56 per barrel, while Brent inched up 1.6% to $46.39.

Gold settled down 0.8% at $1,923.10 per ounce.

The Dollar Index fell by 0.2% at 93.061.

Asia and Australia

The stocks were boosted by the records reached by the American benchmarks amid the possible #COVID-19 vaccine.

Japan225 reached a six-month high after it added 1.35%.

HongKong45 lost 0.17% after a man was found positive for COVID-19 for the second time, confirming, therefore, the hypothesis that reinfection is possible.

Australia200 gained 0.50% even though the Commonwealth Bank of Australia painted a bleak picture of the post-pandemic economic recovery.

USD/JPY was up 0.20% to 106.19.

Europe

The markets followed its peers steps and ended the day on positive territory. Europe50 was up 0.4%, while UK100 added 0.3%. Germany30 rose 0.6%.

EUR/USD traded 0.4% higher at $1.18325.

Sources: reuters.com, investing.com

Esta información preparada por za.capex.com no es una oferta o solicitud con el propósito de comprar o vender ningún producto financiero referido en el presente o participar en una relación legal, ni un consejo o recomendación con respecto a tales productos financieros.

Esta información está preparada para su circulación general. No se refiere a ningún objetivo de inversión específico, situación financiera o necesidad particular de un receptor.

Debería evaluar independientemente cada producto financiero y considerar la idoneidad de dicho producto, teniendo en cuenta sus objetivos de inversión específicos, la situación financiera o las necesidades particulares, y consultar con un asesor financiero independiente si fuera necesario, antes de operar con los productos financieros mencionados en este documento.

Esta información no debe ser publicada, estar en circulación, reproducida o distribuida en su totalidad o en parte a ninguna persona sin el consentimiento previo por escrito de la Compañía.

El rendimiento pasado no es siempre indicativo de las probabilidades o del rendimiento futuro. Todos los puntos de vista y opiniones presentados son exclusivamente del autor y no representan necesariamente las de za.capex.com